The ability of rh Bri2 BRICHOS to prevent Aβ42 oligomer mediated neurotoxicity in vitro and to pass the BBB warrant evaluation of its potential ability to improve AD-like features in animal models, which is the topic of the current study. Here, ITM2B is linked to Alzheimer disease.